In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
A World of Possibilities
A thought leadership article authored by Stephanie Merrigan on the urgent need for more comprehensive and accessible educational tools to enhance patient engagement and retention.
-
The Blockchain Movement
Ronan Fox, VP, Applied Digital Solutions discusses blockchain in clinical trials, particularly as an enabler of virtual trials where patients, providers of services to patients, and the investigators are disbursed around the globe in this recent PharmaVoice article.
-
Embracing Biosimilars
Ioannis Katsoulis, Axel Svedbom, Larushka Mellor and rjan kerborg consider trends and strategies to drive uptake of biosimilars in the UK.
-
The path to successful HTA submissions
For companies launching their products globally, gaining market access and reimbursement through HTA reviews is extremely challenging due to these nuances. Manpreet Sidhu discusses the factors that are key to success in achieving favourable HTA reviews around the world in this Pharmafocus article.
-
Assessing The Impact Of MDR & IVDR On Patients
In Diagnostics World's recent article featuring commentary from ICON experts David Novotny, Angela Brown and Nicole Cowan, they discussed the need to assess the impact of MDR/IVDR on patients after the new medical device regulation is established.
-
Standardised eCOA questionnaire library will speed study start-up
An Outsourcing Pharma article on the collaboration of ICON’s Mapi Research Trust and Medidata to develop a global library of pre-configured, pre-approved eCOA questionnaires to accelerate study start-up, which is being described as “a win-win-win” for all involved.
-
-
New Frontiers
Read PharmaTimes recent article, featuring ICON expert Tom O'Leary, as he discusses his take on how the Internet of Medical Things (loMT) is evolving the patient role in pharma.
-
Regulatory bottlenecks mean EU clinicians & patients could lose access to medical devices under new rules
A recent press release by Samedan LTD Pharmaceutical Publishers on ICON’s scheduled presentation to be given at The Medtech Conference 2019, ‘MDR/IVDR – What now?’, during which our experts will discuss the findings of the whitepaper ‘Higher Costs & Bottlenecks’, looking at the future implications of the new MDR/IVDR rules on the EU market.
-
Making a Difference
How can we encourage more women to pursue STEM careers? Read how ICON is playing a part in this recent Conversis article.
